Recurrent Community-acquired Pneumonia in Patients Starting Acid-suppressing Drugs

American Journal of Medicine

Volumn 123, Issue 1, 2010, Pages 47-53

  Eurich, Dean T ^a   Sadowski, Cheryl A ^a   Simpson, Scot H ^a   Marrie, Thomas J ^a   Majumdar, Sumit R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acid suppression therapy; Pneumonia; Prospective cohort

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

AGED; ARTICLE; CASE CONTROL STUDY; COMMUNITY ACQUIRED PNEUMONIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALBERTA; ANTI-ULCER AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CONFIDENCE INTERVALS; DISEASE SUSCEPTIBILITY; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PNEUMONIA; PROBABILITY; PROTON PUMP INHIBITORS; RECURRENCE; RISK; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 72649102529     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.05.032     Document Type: Article

References (36)

1. Marrie T.J. Epidemiology of community-acquired pneumonia in the elderly. Semin Respir Infect 5 (1990) 260-268
2. Fry A.M., Shay D.K., Holman R.C., et al. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA 294 (2005) 2712-2719
3. Jokinen C., Heiskanen L., Juvonen H., et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 137 (1993) 977-988
4. Laheij R.J., Sturkenboom M.C., Hassing R.J., et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292 (2004) 1955-1960
5. Gulmez S.E., Holm A., Frederiksen H., et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med 167 (2007) 950-955
6. Sarkar M., Hennessy S., and Yang Y.X. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med 149 (2008) 391-398
7. Myles P.R., Hubbard R.B., McKeever T.M., et al. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf 18 (2009) 269-275
8. Majumdar S.R., Soumerai S.B., Farraye F.A., et al. Chronic acid-related disorders are common and underinvestigated. Am J Gastroenterol 98 (2003) 2409-2414
9. Lowe D.O., Mamdani M.M., Kopp A., et al. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis 43 (2006) 1272-1276
10. Bowton D.L., Scuderi P.E., and Haponik E.F. The incidence and effect on outcome of hypoxemia in hospitalized medical patients. Am J Med 97 (1994) 38-46
11. Mowat C., Williams C., Gillen D., et al. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology 119 (2000) 339-347
12. Meuwissen S.G., Craanen M.E., and Kuipers E.J. Gastric mucosal morphological consequences of acid suppression: a balanced view. Best Pract Res Clin Gastroenterol 15 (2001) 497-510
13. Sanduleanu S., Jonkers D., De Bruine A., et al. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther 15 (2001) 379-388
14. Howden C.W., and Hunt R.H. Relationship between gastric secretion and infection. Gut 28 (1987) 96-107
15. Eurich D.T., Marrie T.J., Johnstone J., and Majumdar S.R. Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?. Am J Respir Crit Care Med 178 (2008) 527-533
16. Basi S.K., Marrie T.J., Huang J.Q., and Majumdar S.R. Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes. Am J Med 117 (2004) 305-311
17. Sin D.D., Man S.F., and Marrie T.J. Arterial carbon dioxide tension on admission as a marker of in-hospital mortality in community-acquired pneumonia. Am J Med 118 (2005) 145-150
18. Majumdar S.R., McAlister F.A., Eurich D.T., et al. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 333 (2006) 999
19. Marrie T.J., and Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 127 (2005) 1260-1270
20. Johnstone J., Marrie T.J., Eurich D.T., and Majumdar S.R. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 167 (2007) 1938-1943
21. Johnstone J., Eurich D.T., Majumdar S.R., et al. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore) 87 (2008) 329-334
22. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
23. Skull S.A., Andrews R.M., Byrnes G.B., et al. ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged ≥65 years. Epidemiol Infect 136 (2008) 232-240
24. Aronsky D., Haug P.J., Lagor C., and Dean N.C. Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual 20 (2005) 319-328
25. Fine M.J., Singer D.E., Hanusa B.H., et al. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med 94 (1993) 153-159
26. Kaplan V., Clermont G., Griffin M.F., et al. Pneumonia: still the old man's friend?. Arch Intern Med 163 (2003) 317-323
27. Koivula I., Sten M., and Makela P.H. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med 159 (1999) 1550-1555
28. Lubin J.H., and Gail M.H. Biased selection of controls for case-control analyses of cohort studies. Biometrics 40 (1984) 63-75
29. Essebag V., Platt R.W., Abrahamowicz M., and Pilote L. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol 5 (2005) 5
30. Rosenbaum P.R., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
31. McQuaid K.R., and Laine L. Early heartburn relief with proton pump inhibitors: a systematic review and meta-analysis of clinical trials. Clin Gastroenterol Hepatol 3 (2005) 553-563
32. Howden C.W. Review article: immediate-release proton-pump inhibitor therapy-potential advantages. Aliment Pharmacol Ther 22 Suppl 3 (2005) 25-30
33. Huang J.Q., Goldwater D.R., Thomson A.B., et al. Acid suppression in healthy subjects following lansoprazole or pantoprazole. Aliment Pharmacol Ther 16 (2002) 425-433
34. Bell N.J., and Hunt R.H. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers. Aliment Pharmacol Ther 10 (1996) 897-904
35. Ohning G.V., Barbuti R.C., Kovacs T.O., et al. Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection. Aliment Pharmacol Ther 14 (2000) 701-708
36. Pantoflickova D., Dorta G., Ravic M., et al. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Aliment Pharmacol Ther 17 (2003) 1507-1514